EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Effect of progesterone on cell division in chemically induced endometrial hyperplasia and adeno carcinoma in mice


Cancer Research 38(1): 78-82
Effect of progesterone on cell division in chemically induced endometrial hyperplasia and adeno carcinoma in mice
Cotton string coated with 3-methylcholanthrene (MCA) was implanted in the uterine cavity of ICR mice to induce endometrial hyperplasia and adenocarcinoma. A low dose (total, 2.5 mg) or a high dose (total, 35 mg) of progesterone was administered to the mice at various times during a period of 4-40 wk after MCA application. After serial labeling with [3H]thymidine, the mice were sacrificed, and thymidine-labeling index values of endometrial hyperplasia and adenocarcinoma in progesterone-treated and untreated mice were investigated by autoradiographic techniques. In mice implanted with MCA, there was a progressive increase of hyperplasia and neoplasia as a function of time. The low doses of progesterone administered to the mice caused a significant reduction in labeling with [3H]thymidine in nonatypical hyperplasia and moderate atypical hyperplasia, compared to that for untreated mice. In marked atypical hyperplasia and adenocarcinoma, irrespective of the histological grade, labeling was not reduced. With the high dose of progesterone, marked morphological alterations with degenerative changes were observed in atypical hyperplasia and differentiated adenocarcinoma. Cancer cells were still maximally labeled. The results indicate that the effect of progesterone on nonatypical hyperplasia and moderate atypical hyperplasia is mitotic arrest, whereas the effect on marked atypical hyperplasia and adenocarcinoma is morphological and cytological alterations.


Accession: 005264198

PMID: 618585



Related references

Metabolism and effects of progesterone in the human endometrial adeno carcinoma cell line hec 1. Steroids 35(1): 21-38, 1980

Alterations in carbohydrate metabolism induced by progesterone in cases of endometrial carcinoma and hyperplasia. American Journal of Obstetrics and Gynecology 94(7): 991-996, 1966

Effects of estradiol 17 beta or progesterone on cell arrangement of human endometrial adeno carcinoma cells in vitro and in vivo. Acta Obstetrica et Gynaecologica Japonica (Japanese Edition) 33(12): 2332, 1981

Effect of gestagen therapy on estradiol and progesterone receptor levels and 17 beta hydroxy steroid dehydrogenase in endometrial adeno carcinoma in women. Zeitschrift fuer Krebsforschung und Klinische Onkologie 86(3): 231-242, 1976

Studies on progesterone therapy in the endometrial adeno carcinoma especially about the effect of estrogen priming therapy. Acta Obstetrica Et Gynaecologica Japonica (japanese Edition): 2333, 1981

Hormonal levels in endometrial hyperplasia and adeno carcinoma at menopause. European Journal of Gynaecological Oncology 1(1): 52-62, 1980

Effects of medroxy progesterone on endometrial adeno carcinoma in organotypic culture. Hubinont, P O , F Leroy And P Galand (Edited By) Third International Seminar on Reproductive Physiology And Sexual Endocrinology Basic Actions Of Sex Steroids on Target Organs Ix+296p Illus S Karger: Basel, Switzerland; New York, N Y , U S A 280-283, 1971

Effect of heme oxygenase-1 on induction and development of chemically-induced squamous cell carcinoma in mice. 2011

Disturbance of the regulation of epithelial proliferation with progesterone in the course of carcinogenesis of mouse endometrial adeno carcinoma. Acta Obstetrica et Gynaecologica Japonica (English Edition) 23(4): 303, 1976

Sustained effect of the aromatase inhibitors anastrozole and letrozole on endometrial thickness in patients with endometrial hyperplasia and endometrial carcinoma. Current Medical Research and Opinion 25(5): 1105-1109, 2009